Unbiased spatial proteomics with single-cell resolution in tissues.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
16 06 2022
Historique:
received: 13 02 2022
revised: 05 05 2022
accepted: 18 05 2022
pubmed: 18 6 2022
medline: 22 6 2022
entrez: 17 6 2022
Statut: ppublish

Résumé

Mass spectrometry (MS)-based proteomics has become a powerful technology to quantify the entire complement of proteins in cells or tissues. Here, we review challenges and recent advances in the LC-MS-based analysis of minute protein amounts, down to the level of single cells. Application of this technology revealed that single-cell transcriptomes are dominated by stochastic noise due to the very low number of transcripts per cell, whereas the single-cell proteome appears to be complete. The spatial organization of cells in tissues can be studied by emerging technologies, including multiplexed imaging and spatial transcriptomics, which can now be combined with ultra-sensitive proteomics. Combined with high-content imaging, artificial intelligence and single-cell laser microdissection, MS-based proteomics provides an unbiased molecular readout close to the functional level. Potential applications range from basic biological questions to precision medicine.

Identifiants

pubmed: 35714588
pii: S1097-2765(22)00489-0
doi: 10.1016/j.molcel.2022.05.022
pii:
doi:

Substances chimiques

Proteome 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2335-2349

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests M.M. is an indirect investor in Evosep.

Auteurs

Andreas Mund (A)

Proteomics Program, The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Faculty of Health and Medical Sciences, Blegdamsvej 3B, 2200 Copenhagen, Denmark.

Andreas-David Brunner (AD)

Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany; Boehringer Ingelheim Pharma GmbH & Co. KG, Drug Discovery Sciences, Birkendorfer Str. 65, D-88397, Biberach Riss, Germany.

Matthias Mann (M)

Proteomics Program, The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Faculty of Health and Medical Sciences, Blegdamsvej 3B, 2200 Copenhagen, Denmark; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany. Electronic address: mmann@biochem.mpg.de.

Articles similaires

Humans Artificial Intelligence COVID-19 SARS-CoV-2 Pandemics
Humans Algorithms Software Artificial Intelligence Computer Simulation
Humans Artificial Intelligence Neoplasms Prognosis Image Processing, Computer-Assisted

Classifications MeSH